Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy

• Andrew Haydon,
• Jessica C Hassel,
• Jeffrey A Sosman,
• Sunandana Chandra,
• Ryan Sullivan,
• Mario E Lacouture,
• Meghan J Mooradian,
• Alexander Menzies,
• Douglas B Johnson,
• Fei Ye,
• Prachi Bhave,
• Steven T Chen,
• Georgina Long,
• Briana Rose Halle,
• Farzana Y Zaman,
• Anna K Dewan,
• Rebecca Irlmeier,
• Paras Mehta,
• Nicholas R Kurtansky,
• Jacob S Choi,
• Tracey S Otto,
• Florentia Dimitriou,
• Veronica M Rotemberg

Affiliations

Andrew Haydon

Department of Medical Oncology, Alfred Hospital, Melbourne, Victoria, Australia

Jessica C Hassel

Department of Dermatology, NCT, University Hospital Heidelberg, Heidelberg, Germany

Jeffrey A Sosman

Department of Medicine, Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA

Sunandana Chandra

Department of Medicine, Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA

Ryan Sullivan

Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA

Mario E Lacouture

Memorial Sloan Kettering Cancer Center, New York, New York, USA

Meghan J Mooradian

Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA

Alexander Menzies

Melanoma Institute Australia, North Sydney, New South Wales, Australia

Douglas B Johnson

Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA

Fei Ye

Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA

Prachi Bhave

Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

Steven T Chen

Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA

Georgina Long

Melanoma Institute Australia, North Sydney, New South Wales, Australia

Briana Rose Halle

Vanderbilt University School of Medicine, Nashville, Tennessee, USA

Farzana Y Zaman

Alfred Hospital, Melbourne, Victoria, Australia

Anna K Dewan

Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee, USA

Rebecca Irlmeier

Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA

Paras Mehta

Memorial Sloan Kettering Cancer Center, New York, New York, USA

Nicholas R Kurtansky

Memorial Sloan Kettering Cancer Center, New York, New York, USA

Jacob S Choi

Department of Medicine, Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA

Tracey S Otto

Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey, USA

Florentia Dimitriou

Melanoma Institute Australia, North Sydney, New South Wales, Australia

Veronica M Rotemberg

Memorial Sloan Kettering Cancer Center, New York, New York, USA